BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rao W, Xie M, Yang T, Zhang JJ, Gao W, Deng YL, Zheng H, Pan C, Liu YH, Shen ZY. Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation. World J Gastroenterol 2014; 20(36): 13159-13166 [PMID: 25278711 DOI: 10.3748/wjg.v20.i36.13159]
URL: https://www.wjgnet.com/1007-9327/full/v20/i36/13159.htm
Number Citing Articles
1
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis BWorld Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
2
Palittiya Sintusek, Nawarat Posuwan, Piyaporn Wanawongsawad, Suttiruk Jitraruch, Yong Poovorawan, Voranush Chongsrisawat. High prevalence of hepatitis B-antibody loss and a case report of <i>de novo</i> hepatitis B virus infection in a child after living-donor liver transplantationWorld Journal of Gastroenterology 2018; 24(6): 752-762 doi: 10.3748/wjg.v24.i6.752
3
Chao-Long Chen, Vinod G. Pillai. Operative Techniques in Liver Resection2016; : 255 doi: 10.1007/978-94-017-7411-6_27
4
Zhuolun Song, Chong Dong, Xingchu Meng, Chao Sun, Kai Wang, Hong Qin, Chao Han, Yang Yang, Fubo Zhang, Weiping Zheng, Jing Chen, Keran Duan, Bowen Bi, Wei Gao. Prophylactic Strategy Against De Novo Hepatitis B Virus Infection for Pediatric Recipients Who Receive Hepatitis B Core Antibody–Positive Liver GraftsLiver Transplantation 2021; 27(1): 96 doi: 10.1002/lt.25813
5
Xie Man, Rao Wei. Advancements in the prevention of hepatitis B recurrence by nucleos(t)ide analogue monotherapies after liver transplantationEuropean Journal of Inflammation 2022; 20: 1721727X2211392 doi: 10.1177/1721727X221139254
6
Chong Dong, Zhuolun Song, Jing Chen, Nan Ma, Xingchu Meng, Chao Sun, Keran Duan, Bowen Bi, Kai Wang, Hong Qin, Chao Han, Yang Yang, Fubo Zhang, Weiping Zheng, Wei Gao. Risk factors of de novo hepatitis B virus infection in pediatric hepatitis B core antibody positive liver graft recipients under prophylactic therapyJournal of Gastroenterology and Hepatology 2020; 35(5): 827 doi: 10.1111/jgh.14869